Jubilant Ingrevia commissions new cGMP facility for supplying Niacinamide to global clients
The new facility, which has a capacity of 5,000 metric tonnes, will manufacture nutraceuticals and dietary-active ingredients for human consumption.
The new facility, which has a capacity of 5,000 metric tonnes, will manufacture nutraceuticals and dietary-active ingredients for human consumption.
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
Thiamine Hydrochloride Injection is effective in the treatment of vitamin B1 deficiency (beriberi)
This acquisition will accelerate Medcare's plans to emerge as an international hub for health, beauty, and wellness adding to its existing network of 4 hospitals and over 20 medical centres in the UAE.
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
The long-term partnership aims to make fermentation-based biotin available for the full range of relevant applications as a sustainable, non-chemical, European-sourced alternative
Healtherbs helps in restoring the desired energy levels for daily activity and immunity
Subscribe To Our Newsletter & Stay Updated